Publication:
The circadian timing system as a toxicity target of the anticancer mTOR inhibitor everolimus in mice.

dc.contributor.authorOZTURK, N.
dc.contributor.authorÖZTÜRK, DİLEK
dc.contributor.authorPALA-KARA, Z.
dc.contributor.authorKaptan, Engin
dc.contributor.authorSancar Baş, Serap
dc.contributor.authorÇınar, Suzan
dc.contributor.authorGiachetti, Sylvie
dc.contributor.authorLi, Xiao Mei
dc.contributor.authorLevi, Francis
dc.contributor.authorOKYAR, ALPER
dc.contributor.institutionauthorÖZTÜRK CİVELEK, DİLEK
dc.date.accessioned2019-10-05T21:36:43Z
dc.date.available2019-10-05T21:36:43Z
dc.date.issued2016-06-30
dc.identifier.urihttps://hdl.handle.net/20.500.12645/7753
dc.language.isoen
dc.subjectOZTURK N., ÖZTÜRK D., PALA-KARA Z., Kaptan E., Sancar Baş S., Çınar S., Deniz G., Li X. M. , Giachetti S., Levi F., et al., -The circadian timing system as a toxicity target of the anticancer mTOR inhibitor everolimus in mice.-, 7. European Congress of Pharmacology, İstanbul, Türkiye, 26 June 2016, ss.30
dc.titleThe circadian timing system as a toxicity target of the anticancer mTOR inhibitor everolimus in mice.
dc.typeConference Paper
dspace.entity.typePublication
local.avesis.idc079b0ed-9a06-4952-a44e-5cd57724f574
local.avesis.response7629
relation.isAuthorOfPublication821c461c-752b-4a78-a2e5-a6aaf5076b88
relation.isAuthorOfPublication.latestForDiscovery821c461c-752b-4a78-a2e5-a6aaf5076b88
Files